Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00972270 · ClinicalTrials.gov registry record · Phase 3
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
A Phase 3 study, sponsored by Abiomed.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1
- Enrollment target
NCT00972270 is a Phase 3 study that was terminated before completion, run by Abiomed. The registered enrollment target is 1 participants.
The verdict
NCT00972270, a Phase 3 study, was terminated before completion, sponsored by Abiomed.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a randomized trial investigating the use of the IMPELLA RECOVER LP 2.5 compared to Intra-aortic balloon pump (IABP) in patients with Acute Myocardial Infarction.
Interventions
- DEVICE Impella LP 2.5
- DEVICE Intra-Aortic Balloon Pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00972270
The ClinicalTrials.gov registry entry for NCT00972270 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abiomed, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Impella LP 2.5 is the first listed.
NCT00972270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00972270 about?
NCT00972270 is a clinical study titled "Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability". This is a randomized trial investigating the use of the IMPELLA RECOVER LP 2.5 compared to Intra-aortic balloon pump (IABP) in patients with Acute Myocardial Infarction.
What is the current status of trial NCT00972270?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1 participants. The study started on 2008-07. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00972270?
The interventions under investigation include: Impella LP 2.5 (DEVICE), Intra-Aortic Balloon Pump (DEVICE).
Who is sponsoring clinical trial NCT00972270?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.